The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
Recruiting · NCT07144592 · Interventional (participants receive a specific treatment) · Lead sponsor: Muş Alparslan University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30). The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
Who can take part
Inclusion criteria
- Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
- Being between 18 and 65 years of age,
- Being literate and verbally communicative,
- Being clinically stable (not exhibiting symptoms of acute psychosis),
- Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
- Being cognitively competent enough to participate in individual interviews during the research process,
- Being an individual currently receiving psychiatric treatment and taking medication,
- Agreeing to participate voluntarily in the study and signing a written informed consent form.
Exclusion criteria
- those who do not meet the inclusion criteria
Where it is running
1 location listed.
- Community Mental Health Center - Muş, Turkey (Türkiye)